tm logo
K-HALER
Dead/Cancelled
CANCELLED – SECTION 71

on 05 Jul 2019

Last Applicant/ Owned by

Milton Road

Cambridge, CB4 0AB

GB

Serial Number

79096733 filed on 29th Mar 2011

Registration Number

4251980 registered on 04th Dec 2012

in the Principal Register

Correspondent Address

Michelle L. Visser

Rader, Fishman & Grauer PLLC

39533 Woodward Ave., Ste. 140

Bloomfield Hills MI 48304

Filing Basis

No Filing Basis

Disclaimer

NO DATA

K-HALER

Pharmaceutical preparations for the treatment of respiratory diseases and disorders, asthma, chronic obstructive pulmonary disease (COPD), emphysema, diabetes and human immunodeficiency virus (HIV); pharmaceutical preparations for use in pulmonary delivery systems in the nature of inhalers for the treatment of respiratory diseases and disorders, asthma, chronic obstructive pulmonary disease (COPD)Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of respiratory diseases and disorders, asthma, chronic obstructive pulmonary disease (COPD), emphysema, diabetes and human immunodeficiency virus (HIV); pharmaceutical preparations for use in pulmonary delivery systems in the nature of inhalers for the treatment of respiratory diseases and disorders, asthma, chronic obstructive pulmonary disease (COPD), emphysema, diabetes and human immunodeficiency virus (HIV); inhalers filled with pharmaceutical preparations for the treatment of respiratory diseases and disorders, asthma, chronic obstructive pulmonary disease (COPD), emphysema, diabetes and human immunodeficiency virus (HIV); drug delivery agents in the form of inhalants that release the active ingredients for a wide range of pharmaceuticals; pharmaceutical preparations for use in inhalers, inhalation apparatus, devices and dispensers, namely, drug delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals

Class [010]
Medical Instrument Products


Medical devices, namely, nebulizers for respiration therapy; aerosol dispensers for medical use; inhalers for medical purposes sold empty and inhalers for therapeutic use sold empty; metered dose inhalers for therapeutic use sold empty; nebulizers for administering medication in the form of a mist inhaled into the lungs for treatment of respiratory diseases; and parts and fittings for all the aforesaid goods

Class [016]
Paper Goods and Printed Material


Printed matter, namely, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, series of written articles, reports, printed press releases, promotional literature and product guides in the fields of respiratory diseases and disorders, diabetes and human immunodeficiency virus (HIV); packing paper and cardboard for pharmaceutical packaging; printed patient record cards and prescription pads; pharmaceutical information leaflets; books in the fields of medicine and pharmaceuticals; printed publications, namely, magazines, newsletters, pamphlets, reports, instructional and informational leaflets, and posters, in the fields of medicine and pharmaceuticals; packing paper; stationery; printed instructional and teaching materials in the fields of pharmaceuticals, health care and medicine relating to the pharmaceutical, health care and medical fields

Mark Details


Serial Number

No 79096733

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 66349-0019

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Jun 2020TOTAL INVALIDATION PROCESSED BY THE IB
21st May 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
21st May 2020INVALIDATION PROCESSED
05th Mar 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
15th Aug 2019NEW REPRESENTATIVE AT IB RECEIVED
05th Jul 2019CANCELLED SECTION 71
04th Dec 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19th May 2016INTERNATIONAL REGISTRATION RENEWED
13th Feb 2015NEW REPRESENTATIVE AT IB RECEIVED
30th Mar 2013FINAL DECISION TRANSACTION PROCESSED BY IB